BiotechTube
Home/Revance/Mark J. Foley
MJ

Mark J. Foley

Chief Executive Officer, Director

Revance

Therapeutic Areas

AestheticsNeurology

Revance Pipeline

DrugIndicationPhase
DAXXIFY®Glabellar LinesApproved
RHA® CollectionFacial AestheticsMarketed

Leadership Team at Revance

DS
Dustin S. Sjuts
President
DB
David B. Howton
Chief Financial Officer
RG
Roman G. Rubio, M.D.
Chief Medical Officer
TS
Tobin Schilke
Chief Operations Officer
View full Revance profile